Anbio Biotechnology
NNNNNasdaqHealthcare · In Vitro & In Vivo Diagnostic Substances · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 92,563 | 4.2 | +111.7% |
| Apr 30, 2026 | 43,717 | 1.6 | -16.3% |
| Apr 15, 2026 | 52,247 | 1.9 | +71.3% |
| Mar 31, 2026 | 30,509 | 1.1 | -15.2% |
| Mar 13, 2026 | 35,977 | 1.0 | -26.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Recent SEC filings
All filings ↗- 6-KFORM 6-KMay 19, 2026
- 6-KFORM 6-KApr 27, 2026
- 20-F/AFORM 20-F/A1Apr 9, 2026
- 3Apr 8, 2026
- 3Apr 8, 2026
- 3Apr 8, 2026
- 3Apr 8, 2026
- 3Apr 8, 2026
- 20-FFORM 20-FApr 7, 2026
- 6-KFORM 6-KFeb 17, 2026
- 6-KFORM 6-KJan 26, 2026
- 6-KREPORT OF FOREIGN PRIVATE ISSUERDec 30, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERNov 13, 2025
- 20-FANNUAL REPORTApr 28, 2025
- 6-KREPORT OF FOREIGN PRIVATE ISSUERFeb 21, 2025